Renaissance Technologies
AEMD icon

Renaissance Technologies’s Aethlon Medical AEMD Stock Holding History

Renaissance Technologies’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-920
Closed -$34.4K – 3199
2025
Q3 		$34.4K Buy
+920
New +$53K ﹤0.01% 3389
2025
Q1 		– Sell
-73
Closed -$25.2K – 3418
2024
Q4 		$25.2K Buy
+73
New +$12.4K ﹤0.01% 3468
2023
Q4 		– Sell
-4
Closed -$4K – 3696
2023
Q3 		$4K Sell
4
-1
-20% -$1.28K ﹤0.01% 3606
2023
Q2 		$7K Buy
+5
New +$7.32K ﹤0.01% 3836
2023
Q1 		– Sell
-25
Closed -$28K – 3929
2022
Q4 		$28K Buy
25
+9
+56% +$16.4K ﹤0.01% 3898
2022
Q3 		$36K Buy
+16
New +$69.2K ﹤0.01% 3826
2022
Q2 		– Sell
-68
Closed -$395K – 4183
2022
Q1 		$395K Buy
68
+7
+11% +$41.8K ﹤0.01% 3331
2021
Q4 		$450K Buy
61
+48
+369% +$547K ﹤0.01% 3125
2021
Q3 		$196K Buy
+13
New +$218K ﹤0.01% 3209
2021
Q2 		– Sell
-77
Closed -$622K – 3418
2021
Q1 		$622K Buy
+77
New +$741K ﹤0.01% 2826
2020
Q4 		– Sell
-7
Closed -$37K – 3348
2020
Q3 		$37K Buy
+7
New +$47.4K ﹤0.01% 3297
2020
Q1 		– Sell
-6
Closed -$23K – 3411
2019
Q4 		$23K Buy
+6
New +$71.7K ﹤0.01% 3442

Other funds holding AEMD

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Renaissance Technologies's AEMD Position: Q4 2025 in Review

Renaissance Technologies sold out of Aethlon Medical (AEMD) in Q4 2025, closing a stake of 920 shares — an estimated $34.4K sold.

Renaissance Technologies first reported a position in AEMD in Q4 2019 and held it in 12 quarters. The position peaked at $622K in Q1 2021. 7 funds tracked by Wall St. Rank hold AEMD as of Q4 2025.

  • Renaissance Technologies reported no remaining Aethlon Medical position as of Q4 2025 after selling out during the quarter.
  • Renaissance Technologies sold 920 Aethlon Medical shares in Q4 2025, an estimated $34.4K.
  • Renaissance Technologies first reported a position in Aethlon Medical in Q4 2019 and held it in 12 quarters.
  • Renaissance Technologies's Aethlon Medical position peaked at $622K in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Aethlon Medical as of Q4 2025.

Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.